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ABSTRACT
 
 Phytochemical and antibacterial properties of ethanolic extract of the seeds of African Star 
Apple (Chrysophyllum albidum) were investigated.The phytochemical resultrevealed the presence 
of saponins, carbohydrates, flavonoids, quinones, cardiac glycosides, fatty acids and terpenoids.
The antibacterial activity was studied using agar well diffusion method at different concentrations 
against six pathogenic bacterial strains, three Gram-positive(Staphylococcus aureus, Micrococcus 
variansand Bacillus cereus) and three Gram-negative (Escherichia coli, Pseudomonas aeruginosa 
and Proteus vulgaris). Significant inhibitory activities were exhibited by the ethanolic seed extracts 
for all test organisms except Bacillus cereus. Zone of inhibition of the crude ethanolic extract was 
correlated with that of a standard antibiotic Gentamicin, for antibacterial activity. The results indicated 
a notable inhibition of the bacterial growth.
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INTRODUCTION
 Many people in developing countries 
depend on plants and herbs and concoctions derived 
from plants and herbs for the treatment of ailments1.
Several studies in vitro have revealed that secondary 
metabolites of plant origin function as antimicrobial 
agents2.
 Extracts from different parts, including the 
bark, leaves, roots and seeds of C. albidum have 
been used for the treatment of different ailments, 
such as yellow fever, malaria, certain skin diseases, 
stomach ache, and diarrhoea, vaginal and infertility 
problems as well as dermatological and urinary 
related infections. The extracts have also found use 
as liniments and in stopping microbial growth in 
open wounds3-7.The extracts of the leaves and fruits 
using different solvent of varying polarity have shown 
antimicrobial and antioxidant properties in vitro and 
in vivo8-10.
 Other studies relating to extracts from 
different parts of the plant show that ethanolic extracts 
from the plant significantly reduced blood glucose 
levels and hepatic lipids at higher dose concentrations 
except HDL-cholesterol, which was found to increase 
significantly in diabetic rats11. The extracts were 
also found to reduce platelet concentration12, as 
well as cause reduction in serum levels13. These 
results point to the fact that extracts from this plant 
have antiplatelet, hypolipidemic, hypoglycemic and 
antioxidant properties14.An alkaloid, Eleagnine that 
is known for its anti-nociceptive, anti-inflammatory 
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and antioxidant properties has recently been 
identified as a component of the seed extract10. The 
compounds from the extracts that are responsible 
for these activities are not known, therefore, it is 
necessary to identify the components of the seed 
extract. In this research work we have extracted the 
oil from the seed of C albidum in ethanol with the 
aim of identifying the components of the extract by 
GCMS and LCMS and identifying the specific active 
components. In this report we present a preliminary 
account of the phytochemical and antibacterial 
studies carried out on the ethanolic extract of the 
seed of C.albidumin order to assess the content of 
the extract and the efficacy of its components.
MATERIALS AND METHODS
Seed Collection and Extraction
 Fresh and healthy fruits of the plant 
Chrysophyllum albidum were collected during its 
fruiting season, between January and April 2016, 
from various parts of Canaan land, Ota, Ogun 
State, Nigeria and the seeds removed. Each seed 
was broken up to yield cotyledon and seed coat, 
both of which were ground separately and used in 
the extraction. Both cotyledon and seed coat were 
extracted in the same way.
 The ground powder (200g) of each part of 
the seed was extracted using 1000 mL of ethanol 
in a Soxhlet extractor for 72 h. The ethanol extract 
was concentrated using rotary evaporator. The 
dried extract yielded a dark brown viscous residue 
(43.38 g) which was kept in a refrigerator for further 
analysis.
Preliminary Phytochemical Screening
 The phytochemical screening was 
performed according to the AOAC standards15.
Test Microorganisms and Growth Media
 The following sixpure clinical microbes 
Staphylococcus aureus, Escherichia coli, Bacillus 
cereus, Pseudomonas aeruginosa, Proteus vulgaris 
and Micrococcus varians wereincubated for 24 
hours at 37°C on nutrient agar. The bacterial strains 
were grown in Mueller-Hinton agar (MHA) plates at 
37°Candmaintainedat 4°C.
Susceptibility Test
 Antibacterial activities of theethanolic 
extracts were examined against six pathogenic 
strains,Staphylococcus aureus, Escherichia coli, 
Bacillus cereus, Pseudomonas aeruginosa, Proteus 
vulgaris and Micrococcus varians by the agar disk 
diffusion method. The dissolved extracts in dimethyl 
sulfoxide were filtered with sintered glass filter and 
stored at 4°C.Stock solutions of the test extracts 
at different concentrations were prepared using 
acetone/water (1:1) mixture as solvent. The plates 
were incubated at 37°C for 24 h. The sensitivity test 
was done in triplicate and the mean zone of inhibition 
was taken.The zones of growth inhibition were 
measured following 18 to 24 h incubation at 37°C. 
Microorganism susceptibilityto the seed extracts 
were measured based on the sizes of inhibitory 
zones (including the diameter of disk) on the agar 
surface over the disks. Control experiments were 
carried out using Gentamicin as standard drug.
Determinat ion  of  Min imum inhib i tory 
concentration (MIC)
 MIC values were determined by the macro-
broth dilution technique.The minimum inhibitory 
concentration was determined foreach bacterium, 
that is,Staphylococcus aureus, Escherichia coli, 
Bacillus cereus, Pseudomonas aeruginosa, Proteus 
vulgaris and Micrococcus varians using broth dilution 
method. Two-fold serial dilutions of the extracts were 
prepared in concentrations of 50, 25, 12.5, 6.25, 
3.125 and 1.563 mg/mL. The cultures were incubated 
at 37°C for 24 h, with shaking. Having obtained 
different concentration of the compounds in the 
broth, 0.1 mL of the standard inoculums of the micro-
organisms in the normal saline was then inoculated 
into different concentration in the test tubes and the 
test tubes were incubated at 37°C for 24 h. The least 
concentrations that that induced 100% inhibition 
were used to determine MIC values.
RESULTS
Preliminary phytochemical screening
 T h e e t h a n o l i c  c r u d e  ex t ra c t s  o f 
Chrysophyllum albidum seed were found to contain 
saponins, carbohydrates, flavonoids, quinones, 
cardiac glycosides, fatty acids and terpenoids as 
presented in Table 1.
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Antibacterial activity
 Tables 2 and 3 show the results of 
the antibacterial screening and the minimum 
inhibitory concentrations of the crude extracts of 
Chrysophyllum albidum.
DISCUSSIONS
 
 In the screening test, ethanolic extracts 
from the seed of Chrysophyllum albidum were found 
to be effective against Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa, Proteus 
vulgaris and Micrococcus varians. The results as 
shown in table 2 suggest that the crude extracts 
obtained from the seed ofC.albidum showed strong 
activity against most of the test bacterial strains when 
compared with Gentamicin standard.
 A closer look at the figures in Table 3 shows 
that apart from Staphylococcus aureus the measured 
MIC was lower for the seed coat extract than the 
cotyledon extract. This could be an indication that the 
seed coat extract possesses more active and potent 
components. Our result supports that previously 
presented by Imaga and Urua16 antibacterial activity 
of ethanolic and water extracts of C. albidum.
 Similar phytochemicals as obtained in Table 
2 have also been reported by Imaga and Urua8 like 
saponins, terpenoids, cardiac glycosides, quinones, 
flavonoids, fatty acids and carbohydrates with 
biological activities and beneficial therapeutic index 
is revealed in this contemporary investigation.
 In this research we have shown that 
the extracts from the seed of C.albidum (African 
Star Apple), has secondary metabolites such as 
saponins, terpenoids, cardiac glycosides, quinones, 
flavonoid, acids and carbohydrates which may 
contribute to pharmacognosy.
 These metabolites are available to humans, 
animals and higher plants, as they help to protect 
against infectious diseases. The antibacterial activity 
study which showed that the extracts from the 
seed were active against Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa, Proteus 
vulgaris and Micrococcus varians suggests that the 
seed extract contain components that can be used as 
antibacterial agents. This study, although the extracts 
from the seed are not usually used in traditional 
medicine, substantiates the claim that extracts 
Table 1: Phytochemical Analysis of Ethanolic 
Crude Extracts from Chrysophyllum albidum
 Cotyledon Seed Coat
Saponins + -
Carbohydrates + +
Flavonoids + -
Quinones + -
Cardiac Glycosides + +
Terpenoids + -
Fatty Acids + +
Table 2:Antibacterial susceptibility test of 
extracts of Chrysophyllum albidum Seed
 Cotyledon Seed Gentamicin
  Coat (Control)
  Zones of Inhibition (mm)
Staphylococcus 17 18 16
aureus
Escherichia coli 16 - 18
Bacillus cereus - - 8
Pseudomonas 13 18 Resistance
aeruginosa
Proteus vulgaris 13 14 18
Micrococcus 12 - 11
varians
Table 3: Minimum Inhibitory Concentration
 Cotyledon  Seed Coat
                             Minimum Inhibitory
                                    Concentration (mg/mL)
Staphylococcus 12.50  25.00
aureus
Escherichia coli 6.50  -
Bacillus cereus -  -
Pseudomonas 50.00  6.25
aeruginosa
Proteus vulgaris 12.50  6.25
Micrococcus 50.00  -
varians
-Represents No Activity
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from various parts of the plant have been used in 
the traditional medicine to cure various contagious 
diseases caused by the microbes; therefore seed 
extracts should be considered along with other parts 
of the tree. Additional studies should be carried 
outto better appraise the potential capability of the 
crude extracts as antibacterial agents. More studies, 
towards the isolation and structural elucidation of the 
antibacterial effective components from the plant 
have commenced.
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